FDA NDC Directory · JSON-LD · Markdown

Revcovi

NDC 10122-502 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameelapegademase-lvlr
Labeler / ManufacturerChiesi USA, Inc.
Marketing categoryBiologic License Application · App BLA761092
Dosage form / routeINJECTION · INTRAMUSCULAR
Active ingredientsELAPEGADEMASE (1.6 mg/mL)
Marketing started20181005
Package count1

External sources

Source: openFDA. Public-domain (CC0).